Identification of CD8 T-cell dysfunction associated with symptoms in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and Long COVID and treatment with a nebulized antioxidant/anti-pathogen agent in a retrospective case series

The study titled “Identification of CD8 T-cell dysfunction associated with symptoms in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and Long COVID and treatment with a nebulized antioxidant/anti-pathogen agent in a retrospective case series” provides critical insights into the potential pathogenesis and treatment of Long COVID and ME/CFS. Here’s a detailed summary: Background: Methods and Findings: Conclusions: In summary, this study sheds light on the underlying immune dysfunction in Long COVID and ME/CFS and opens avenues for potential treatment strategies that target this dysfunction. Read More: https://www.sciencedirect.com/science/article/pii/S2666354623001345

Brainstem volume changes in myalgic encephalomyelitis/chronic fatigue syndrome and long COVID patients

The study “Brainstem Volume Changes in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Long COVID Patients” provides insightful findings on the neurological aspects of ME/CFS and long COVID. Here’s a summary: This research contributes to the understanding of the neurological impacts of ME/CFS and long COVID, highlighting the significance of brainstem changes in these conditions.​ Read More: https://www.frontiersin.org/articles/10.3389/fnins.2023.1125208/full